Advertisement
U.S. Markets close in 4 hrs 55 mins

Eupraxia Pharmaceuticals Inc. (EPRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W
3.1086-0.0514 (-1.63%)
As of 04:00PM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
31,850
27,847
17,617
14,649
1,761
Operating Income
-31,850
-27,847
-17,617
-14,649
-1,761
Net Non Operating Interest Income Expense
5.349
-307.204
-551.057
-965.4437
-1,475
Other Income Expense
4,156
-775.15
-822.255
-2,714
91.5658
Pretax Income
-27,688
-28,930
-18,991
-18,329
-3,145
Tax Provision
36.423
36.423
0
-
-
Net Income Common Stockholders
-26,999
-28,221
-18,490
-18,031
-3,135
Diluted NI Available to Com Stockholders
-26,999
-28,221
-18,490
-18,031
-3,135
Basic EPS
-1.53
-1.17
-0.96
-1.47
-0.24
Diluted EPS
-1.53
-1.17
-0.96
-1.47
-0.24
Basic Average Shares
22,702
24,147
19,285
12,406
12,865
Diluted Average Shares
22,702
24,147
19,285
12,406
12,865
Rent Expense Supplemental
-
-
-
-
30.9255
Total Expenses
31,850
27,847
17,617
14,649
1,761
Net Income from Continuing & Discontinued Operation
-26,999
-28,221
-18,490
-18,031
-3,135
Normalized Income
-30,531
-27,756
-17,667
-17,089
-3,226
Interest Income
1,185
862.969
431.799
51.5506
0.3349
Interest Expense
1,180
1,170
982.856
1,017
1,476
Net Interest Income
5.349
-307.204
-551.057
-965.4437
-1,475
EBIT
-26,508
-27,759
-18,008
-17,312
-1,670
EBITDA
-26,349
-27,604
-17,860
-17,224
-1,578
Reconciled Depreciation
159.397
155.527
147.894
87.4724
91.6034
Net Income from Continuing Operation Net Minority Interest
-26,999
-28,221
-18,490
-18,031
-3,135
Total Unusual Items Excluding Goodwill
4,156
-775.15
-822.255
-941.5044
91.5658
Total Unusual Items
4,156
-775.15
-822.255
-941.5044
91.5658
Normalized EBITDA
-30,505
-26,829
-17,038
-16,283
-1,670
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
623.4531
-310.06
0
0
0